Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Alice Zervoudakis"'
Autor:
Bobby Daly, Kevin J. Nicholas, Jessica Flynn, Katherine S. Panageas, Nicholas Silva, Elaine Duck, Alice Zervoudakis, Jessie Holland, Rori Salvaggio, Aaron Begue, Isaac Wagner, Stefania Sokolowski, Melissa Zablocki, Yeneat O. Chiu, Gilead J. Kuperman, Brett A. Simon, Wendy Perchick, Diane L. Reidy‐Lagunes
Publikováno v:
JCO oncology practice. 18(12)
1578 Background: Acute care visits (emergency department [ED] visits or inpatient admissions) for patients with cancer are growing disproportionately. Traditional oncology care models have not effectively identified and managed at-risk patients to pr
Autor:
Bill H. Diplas, Ryan Ptashkin, Joanne F. Chou, Shalom Sabwa, Michael B. Foote, Benoit Rousseau, Guillem Argilés, James Robert White, Caitlin M. Stewart, Kelly Bolton, Sree B. Chalasani, Avni M. Desai, Zoe Goldberg, Ping Gu, Jia Li, Marina Shcherba, Alice Zervoudakis, Andrea Cercek, Rona Yaeger, Neil H. Segal, David H. Ilson, Geoffrey Y. Ku, Ahmet Zehir, Marinela Capanu, Yelena Y. Janjigian, Luis A. Diaz, Steven B. Maron
Publikováno v:
JAMA Network Open. 6:e2254221
ImportanceClonal hematopoiesis (CH) has been associated with development of atherosclerosis and leukemia and worse survival among patients with cancer; however, the association with cancer therapy efficacy, in particular immune checkpoint blockade (I
Autor:
Fergus Keane, Joshua David Schoenfeld, Fionnuala Crowley, Catherine Anne O'Connor, Charlie White, Carly Schwartz, Robin Brenner, Mary Larsen, Wungki Park, Anna M. Varghese, Kenneth H. Yu, Jia Li, Alice Zervoudakis, Zoe Goldberg, Joanne F. Chou, Santosha Vardhana, Marsha Reyngold, Christopher H Crane, Richard Tuli, Eileen Mary O'Reilly
Publikováno v:
Journal of Clinical Oncology. 41:725-725
725 Background: Immune checkpoint blockade (ICB) has a modest signal in the treatment of patients with genomically unselected pancreatic cancer (PDAC). Synergistic effects of combined radiotherapy and ICB are postulated. Preliminary results of a phas
Autor:
Bobby Daly, Kevin Nicholas, Jessica Flynn, Nicholas Silva, Katherine Panageas, Jun J. Mao, Lior Gazit, Dmitriy Gorenshteyn, Stefania Sokolowski, Tiffanny Newman, Claire Perry, Isaac Wagner, Alice Zervoudakis, Rori Salvaggio, Jessie Holland, Yeneat O. Chiu, Gilad J. Kuperman, Brett A. Simon, Diane L. Reidy-Lagunes, Wendy Perchick
Publikováno v:
JAMA Network Open. 5:e221078
Electronic patient-reported outcomes (ePROs) may have the potential to improve cancer care delivery by enhancing patient quality of life, reducing acute care visits, and extending overall survival. However, the optimal cadence of ePRO assessments is
Autor:
Hrudaya Veena Yanamandala, Nicholas Silva, Isaac Wagner, Bobby Daly, Javiera Arenas, Wendy Perchick, Stephen R. Veach, Yeneat O. Chiu, Gilad J. Kuperman, Stefania Sokolowski, Claire Perry, Rachel N. Grisham, Kim Chow, Stephanie Hirsch, Chasity Burrows Walters, Jessie C. Holland, Alice Zervoudakis, Rori Salvaggio, Ankita Roy, Amandeep K. Dhami, Diane Reidy-Lagunes, Emily Brown, Margarita Rozenshteyn, Brett A Simon, Aaron Begue, Chau T. Dang, Alice S. Ro, Tara Lauria, Lauren L. Katzen, Raj Kottamasu, Abigail Baldwin Medsker, Melissa Zablocki
Publikováno v:
JCO Oncol Pract
PURPOSE: Early detection and management of symptoms in patients with cancer improves outcomes. However, the optimal approach to symptom monitoring and management is unknown. InSight Care is a mobile health intervention that captures symptom data and
Autor:
Jonathan T Kapke, Melissa Zablocki, Elizabeth Malosh, Ravi Narra, Jessie C. Holland, Alice Zervoudakis, John D Sprandio, Laura C. Michaelis, Bobby Daly
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 40
Patients with cancer frequently seek acute care as a result of complications of their disease and adverse effects of treatment. This acute care comes at high cost to the health care system and often results in suboptimal outcomes for patients and the
Autor:
David P. Kelsen, Rebecca J. Nagy, Michal Segal, Yelena Y. Janjigian, Walid K. Chatila, Steven B Maron, Brittanie M Millang, Ryan Ptashkin, Marc Simmons, David H. Ilson, Marina Shcherba, Nikolaus Schultz, Parisa Momtaz, David B. Solit, Alice Zervoudakis, Marinela Capanu, Geoffrey Y. Ku, Mark T.A. Donoghue, Shweta S. Chavan, Richard B. Lanman, Joanne F. Chou, Elizabeth Won, Jaclyn F. Hechtman, Carly Alterman, Barry S. Taylor
Publikováno v:
Lancet Oncol
BACKGROUND: Adding trastuzumab to first-line chemotherapy improves overall survival in patients with HER2-positive metastatic gastric cancer. We assessed the safety and efficacy of pembrolizumab in combination with trastuzumab and chemotherapy in fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eab8cf760fd6ad5ed7be361a27303af
https://europepmc.org/articles/PMC8229851/
https://europepmc.org/articles/PMC8229851/
Autor:
Wendy Perchick, Kevin Nicholas, Lauren L. Katzen, Claire Perry, Stefania Sokolowski, Dmitriy Gorenshteyn, Isaac Wagner, Alice Zervoudakis, Diane Reidy-Lagunes, Lynn Adams, Rori Salvaggio, Margarita Rozenshteyn, Han Xiao, Lior Gazit, Brett A Simon, Yeneat O. Chiu, Bobby Daly, Abigail Baldwin Medsker
Publikováno v:
JCO Clin Cancer Inform
PURPOSE To create a risk prediction model that identifies patients at high risk for a potentially preventable acute care visit (PPACV). PATIENTS AND METHODS We developed a risk model that used electronic medical record data from initial visit to firs
Publikováno v:
Visceral Medicine. 33:47-53
Background: The liver is the most common site for metastases from colorectal cancer (CRC) with the majority of these patients having unresectable disease. Methods: This is a retrospective review of studies using hepatic arterial infusion (HAI) therap
Autor:
Shalom Sabwa, Alice Zervoudakis, Yelena Y. Janjigian, Zoe Goldberg, Avni M. Desai, Steven Brad Maron, Bill H. Diplas, Rona Yaeger, Kelly L. Bolton, Luis A. Diaz, Ryan Ptashkin, Ping Gu, Andrea Cercek, Ahmet Zehir, Sree Bhavani Chalasani, Jia Li, Marina Shcherba
Publikováno v:
Journal of Clinical Oncology. 39:e16082-e16082
e16082 Background: Clonal hematopoiesis (CH) represents non-random clonal selection of bone marrow-derived cells marked by somatic mutations in certain genes. The presence of CH is associated with development of atherosclerosis and leukemia, and acce